Last night, President Donald J. Trump officially unveiled TrumpRx.gov, a transformative new government platform that gives Americans direct access to dramatically lower prices on dozens of common, high-cost brand-name prescription drugs. Secured through landmark Most-Favored-Nation pricing agreements with leading pharmaceutical manufacturers, these deals ensure Americans pay prices aligned with the lowest in other developed nations, ending decades of overpayment and delivering immediate relief.
Starting today, American patients — especially the millions who face high out-of-pocket costs for medications not fully covered by insurance — can access substantially lower prices on dozens of essential drugs via TrumpRx.gov. As the Trump Administration pursues the best possible deals for the American people, additional high-cost medications will be added on a rolling basis.
Key examples of the savings include:
GLP-1 medications — among the highest-spend drugs in the U.S. — have dramatic price reductions on TrumpRx.gov.
- The monthly prices of Ozempic® and injectable Wegovy® drop from $1,028 and $1,349, respectively, to an average of $350 and as low as $199, depending on dosage.
- The monthly price of the Wegovy® pill falls from $1,349 to as low as $149, depending on dosage.
- The monthly price of Zepbound® falls from $1,088 to an average of $346 and as low as $299, depending on dosage.
Millions of Americans struggling with infertility often pay for fertility treatments entirely out-of-pocket. Thanks to TrumpRx.gov, they stand to save an average of $2,000+ per cycle on common medications.
- The price of Gonal-F® — one of the most commonly-used fertility drugs — falls to as low as $168 per pen, depending on dosage.
- The price of Cetrotide® — another commonly used fertility drug — falls from $316 to $22.50.
- The price of Ovidrel® falls from $251 to $84.
This launch marks only the beginning.
The Trump Administration will be onboarding additional companies that have Most-Favored-Nation agreements and is aggressively pursuing additional agreements to expand the platform — ultimately driving even greater savings for Americans on prescription drugs.
For Americans who obtain their prescriptions through insurance, President Trump calls on Congress to swiftly pass his Great Healthcare Plan. This comprehensive reform would codify the savings from the Most-Favored-Nation initiative, lower insurance premiums, hold big insurance companies accountable, maximize price transparency, and enable coverage of TrumpRx.gov purchases under health plans — ensuring every American benefits from these historic reductions in drug costs.